Product Information
CHLD ALLRGY RLF 12.5 MG CHEW TB is a generic product labeled by AmerisourceBergen, priced at $0.1130 per EA under NDC 46122042589. Its NADAC has been published 315 times since Sep 23, 2020.
Strength
12.5 mg/1
Manufacturer
AmerisourceBergenNDC
46122042589
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
DIPHENHYDRAMINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
4/25/2011
Pharmacological Classes
Price Statistics
The NADAC for CHLD ALLRGY RLF 12.5 MG CHEW TB has been published 315 times since Sep 23, 2020, and over the history we have for it it has risen 13.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1130 per EA |
|---|---|
| All-time high | $0.1130 (Sep 30, 2026) |
| All-time low | $0.1000 (Sep 23, 2020) |
| 52-week high | $0.1130 |
| 52-week low | $0.1130 |
| Median price | $0.1085 |
| Average price | $0.1072 |
| Largest weekly change | +7.5% (Aug 23, 2023) |
| Weeks tracked | 315 |
| Tracking since | Sep 23, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the diphenhydramine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diphenhydramine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLD ALLRGY RLF 12.5 MG CHEW TB?
The current National Average Drug Acquisition Cost (NADAC) for CHLD ALLRGY RLF 12.5 MG CHEW TB, manufactured by AmerisourceBergen, is $0.1130 per EA (NDC 46122042589), effective Sep 30, 2026.
How has the price of CHLD ALLRGY RLF 12.5 MG CHEW TB changed over time?
Over the history we have for it, the NADAC for CHLD ALLRGY RLF 12.5 MG CHEW TB has risen 13.0%. It has been tracked across 315 weekly CMS publications since Sep 23, 2020.
What are the highest and lowest recorded NADAC prices for CHLD ALLRGY RLF 12.5 MG CHEW TB?
Since Sep 23, 2020, the NADAC for CHLD ALLRGY RLF 12.5 MG CHEW TB has ranged from a low of $0.1000 (Sep 23, 2020) to a high of $0.1130 (Sep 30, 2026), with a median of $0.1085 per EA.
Are there cheaper alternatives to CHLD ALLRGY RLF 12.5 MG CHEW TB?
No other NADAC-published product currently shares the active ingredient and strength of CHLD ALLRGY RLF 12.5 MG CHEW TB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHLD ALLRGY RLF 12.5 MG CHEW TB?
CHLD ALLRGY RLF 12.5 MG CHEW TB (NDC 46122042589) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.